This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...